An open-label, 2-period, sequential treatment, drug interaction study to evaluate the effect of low-dose ritonavir on bupropion pharmacokinetics in healthy volunteers

Trial Profile

An open-label, 2-period, sequential treatment, drug interaction study to evaluate the effect of low-dose ritonavir on bupropion pharmacokinetics in healthy volunteers

Not stated
Phase of Trial: Phase I

Latest Information Update: 12 Jul 2007

At a glance

  • Drugs Bupropion (Primary) ; Ritonavir
  • Indications HIV infections; Major depressive disorder; Seasonal affective disorder; Smoking withdrawal
  • Focus Pharmacokinetics
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 12 Jul 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top